Glaxosmithkline Share News (GSK)

Generic drug companies win fight to make Pronova's Lovaza

WASHINGTON, Sept 12 (Reuters) - Generic drug companies can develop generic versions of Lovaza, a fish-oil derived drug used to treat high cholesterol, a U.S. appeals court ruled on Thursday. In April 2009, Pronova BioPharma Norge AS filed a patent infringement lawsuit in Delaware against Te

UPDATE 1-China drugmaker Sino Biopharmaceutical investigating TV corruption report

By Adam Jourdan SHANGHAI, Sept 12 (Reuters) - Chinese drug company Sino Biopharmaceutical Ltd has set up a team to investigate allegations broadcast on state television that its majority-owned subsidiary had paid for illegal overseas trips for doctors, it said on Thursday. Regional sa

China drugmaker Sino Biopharmaceutical investigating TV corruption report

By Adam Jourdan SHANGHAI, Sept 12 (Reuters) - Chinese drug company Sino Biopharmaceutical Ltd has set up a team to investigate allegations broadcast on state television that its majority-owned subsidiary had paid for illegal overseas trips for doctors, it said on Thursday. Regional sa

REUTERS SUMMIT-Reckitt Benckiser hungry for new health deals

* CEO expects shakeout in fragmented consumer health market * Company has firepower to do sizeable deals * RB likely to see disposals as well as acquisitions (Adds more comments, background) By Martinne Geller and Ben Hirschler LONDON, Sept 11 (Reuters) - Reckitt Benckis

Broker tips: GlaxoSmithKline, Glencore Xstrata, Whitbread

Panmure Gordon has kept its positive stance on pharmaceuticals group GlaxoSmithKline, despite recent concerns over rising competition from generic versions of its Advair drug, recommending investors to 'buy' on weakness. The broker said that there are still a number of regulatory process steps and

South Africa's Aspen profit rises, it plans Russia campaign

JOHANNESBURG, Sept 11 (Reuters) - South Africa's Aspen Pharmacare said on Wednesday its full-year earnings rose by a quarter, helped by strong performance at home and overseas, and it was planning a push into Russia. Aspen, Africa's largest maker of generic drugs, said diluted headline earn

REUTERS SUMMIT-Reckitt Benckiser hungry for new health deals

By Martinne Geller and Ben Hirschler LONDON, Sept 11 (Reuters) - Reckitt Benckiser Group will be a major player in a coming shakeout of the global consumer health industry and has the capability to do sizeable deals, according to its chief executive. Speaking at the Reuters Consumer

China drugmaker Gan & Lee investigating allegations it paid $130 mln in bribes

By Adam Jourdan SHANGHAI, Sept 11 (Reuters) - Chinese insulin maker Gan & Lee Pharmaceuticals said on Wednesday it was investigating allegations published in a newspaper that it spent around 800 million yuan ($130.72 million) to bribe doctors to promote the firm's drugs over five years.

Broker snap: 'Buy' Glaxo despite fears over generics, says Panmure

Panmure Gordon has kept its positive stance on pharmaceuticals group GlaxoSmithKline, despite recent concerns over rising competition from generic drugs, recommending investors to 'buy' on weakness. GSK's share price sunk 2.5% on Tuesday after the US Food and Drug Administration (FDA) published dra

London pre-open: Stocks seen higher as Syria concerns recede

Stocks are expected to edge higher on Wednesday morning as tensions over Syria continue to ease. Markets rose strongly on Tuesday after Syria accepted a Russian proposal to hand over all chemical weapons to international control in an attempt to avoid US military action. In a nationally televised

UPDATE: Glaxo Gets Recommendation For Anoro Ellipta

GSK and Theravance receive FDA approval for COPD treatment in US

GlaxoSmithKline (GSK) has, alongside partner Theravance, announced that the US Food and Drug Administration's (FDA) Pulmonary-Allergy Drugs Advisory Committee (PADAC) has recommended approval of their latest treatment for chronic obstructive pulmonary disease (COPD) in the US. The committee voted

FDA Panel Votes In Favor Of Glaxo-Theravance's Lung Drug

UPDATE 1-FDA panel supports approval of Glaxo lung drug Anoro

(Updates with details from panel meeting) By Toni Clarke WASHINGTON, Sept 10 (Reuters) - A federal advisory panel recommended approval of GlaxoSmithKline's new drug to treat chronic obstructive pulmonary disease (COPD), and suggested the company be required to conduct further safety s

FDA panel votes in favor of approval of Glaxo lung drug Anoro

WASHINGTON, Sept 10 (Reuters) - An federal advisory panel has recommended that the U.S. Food and Drug Administration approve a drug made by GlaxoSmithKline Plc and Theravance Inc to treat chronic obstructive pulmonary disease. The panel voted 11-2 to approve the drug, Anoro, an inhaled comb